Sarah Karlovitch

The designation follows durable responses seen in a phase 1 study of the agent.

A new TIL therapy seeks to improve on current treatments for metastatic non-small cell lung cancer such as PD-1 inhibitors.

A post-hoc analysis overviewed long-term efficacy of autologous hematopoietic stem cell transplantation in mantle cell lymphoma.

FT516 and FT595 are both currently being evaluated in phase 1 trials for B-cell malignancies.

The non-randomized, open-label trial of AIC100 is currently recruiting patients at the Weill Cornell Medical College in in New York.

The TiTAN-1 clinical trial is assessing the effect of GEN-011 on melanoma and various types of carcinomas.

Alison R. Sehgal, MD, discusses the latest developments with CAR T-cell therapy in lymphomas.